Tvardi Therapeutics, Inc.
TVRD
$3.75
-$0.16-4.09%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 36.46M | 40.99M | 22.31M | 31.61M | 9.44M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.98M | 2.14M | 1.15M | 72.00K | 1.27M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 38.44M | 43.13M | 23.46M | 31.69M | 10.70M |
|
|
|||||
| Total Current Assets | 38.44M | 43.13M | 23.46M | 31.69M | 10.70M |
| Net Property, Plant & Equipment | 223.00K | 249.00K | 275.00K | 300.00K | 310.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 338.00K | 354.00K | 369.00K | 385.00K | 401.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 17.00K | 17.00K | 3.71M | 2.83M | 1.10M |
| Total Assets | 39.02M | 43.75M | 27.81M | 35.20M | 12.51M |
|
|
|||||
| Total Accounts Payable | 4.08M | 2.43M | 1.69M | 2.19M | 1.98M |
| Total Accrued Expenses | 6.85M | 8.14M | 5.21M | 8.08M | 3.24M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 113.00K | 109.00K | 106.00K | 103.00K | 92.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 11.04M | 10.68M | 7.00M | 10.37M | 5.31M |
|
|
|||||
| Total Current Liabilities | 11.04M | 10.68M | 7.00M | 10.37M | 5.31M |
| Long-Term Debt | -- | -- | 35.76M | 30.26M | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 115.00K | 145.00K | 174.00K | 201.00K | 207.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 11.16M | 10.82M | 42.93M | 40.83M | 5.51M |
|
|
|||||
| Common Stock & APIC | 131.03M | 130.59M | 1.19M | 1.11M | 1.03M |
| Retained Earnings | -103.18M | -97.65M | -101.82M | -92.24M | -79.53M |
| Treasury Stock & Other | 7.00K | -13.00K | 2.00K | -- | -- |
| Total Common Equity | 27.87M | 32.93M | -100.63M | -91.13M | -78.50M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | 85.50M | 85.50M | 85.50M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | 85.50M | 85.50M | 85.50M |
|
|
|||||
| Total Common Equity | 27.87M | 32.93M | -100.63M | -91.13M | -78.50M |
| Total Preferred Equity | -- | -- | 85.50M | 85.50M | 85.50M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 27.87M | 32.93M | -15.12M | -5.63M | 7.00M |
|
|
|||||